Mannkind (MNKD) Total Debt (2010 - 2026)
Mannkind (MNKD) reported Total Debt of $103.2 million for Q1 2026, down 0.55% year-over-year from $103.8 million in Q1 2025, and little changed on a QoQ basis from $103.4 million in Q4 2025.
Mannkind (MNKD) has 17 years of Total Debt data on file, last reported at $103.2 million in Q1 2026.
- Quarterly Total Debt fell 0.55% year-over-year to $103.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $103.2 million (down 0.55% YoY) and the FY2025 annual result came in at $103.4 million, changed 0.5% from the prior year.
- Total Debt steadied at $103.2 million in Q1 2026 per MNKD's latest filing, from $103.4 million in the prior quarter.
- Across five years, Total Debt topped out at $104.1 million in Q4 2023 and bottomed at $8.8 million in Q4 2022.
- The 5-year median for Total Debt is $103.6 million (2025), against an average of $78.4 million.
- The widest annual swing landed in 2023, when Total Debt soared 1079.17%; it then declined 19.49% in 2025.
- Tracing MNKD's Total Debt over 5 years: stood at $8.8 million in 2022, then soared by 1079.17% to $104.1 million in 2023, then declined by 0.16% to $103.9 million in 2024, then declined by 0.5% to $103.4 million in 2025, then slipped by 0.22% to $103.2 million in 2026.
- Per Business Quant, the three latest MNKD Total Debt figures stand at $103.2 million (Q1 2026), $103.4 million (Q4 2025), and $83.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 319.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.99 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | 103.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 103.19 Mn |
| Dec 31, 2025 | 103.42 Mn |
| Sep 30, 2025 | 83.73 Mn |
| Jun 30, 2025 | 103.70 Mn |
| Mar 31, 2025 | 103.77 Mn |
| Dec 31, 2024 | 103.94 Mn |
| Sep 30, 2024 | 104.00 Mn |
| Jun 30, 2024 | 104.00 Mn |
| Dec 31, 2023 | 104.11 Mn |
| Sep 30, 2023 | 8.83 Mn |
| Jun 30, 2023 | 8.83 Mn |
| Dec 31, 2022 | 8.83 Mn |
| Jun 30, 2021 | 4.87 Mn |
| Mar 31, 2021 | 4.87 Mn |
| Dec 31, 2020 | 4.87 Mn |
| Sep 30, 2020 | 1.42 Mn |
| Jun 30, 2020 | 2.03 Mn |
| Jun 30, 2019 | 80.96 Mn |
| Mar 31, 2019 | 83.42 Mn |
| Dec 31, 2018 | 83.39 Mn |
| Sep 30, 2018 | 86.35 Mn |
| Jun 30, 2018 | 110.20 Mn |
| Mar 31, 2018 | 115.90 Mn |
| Dec 31, 2017 | 132.41 Mn |
| Sep 30, 2017 | 137.61 Mn |
| Jun 30, 2017 | 137.15 Mn |
| Mar 31, 2017 | 121.32 Mn |
| Dec 31, 2016 | 120.86 Mn |
| Sep 30, 2016 | 120.41 Mn |
| Jun 30, 2016 | 124.97 Mn |
| Mar 31, 2016 | 124.53 Mn |
| Dec 31, 2015 | 124.10 Mn |
| Sep 30, 2015 | 123.68 Mn |
| Jun 30, 2015 | 123.28 Mn |
| Mar 31, 2015 | 122.89 Mn |
| Dec 31, 2014 | 122.52 Mn |
| Sep 30, 2014 | 81.83 Mn |
| Jun 30, 2014 | 87.27 Mn |
| Mar 31, 2014 | 49.52 Mn |
| Dec 31, 2013 | 120.70 Mn |
| Sep 30, 2013 | 119.64 Mn |
| Dec 31, 2012 | 119.64 Mn |
| Sep 30, 2012 | 223.14 Mn |
| Jun 30, 2012 | 218.14 Mn |
| Mar 31, 2012 | 283.45 Mn |
| Dec 31, 2011 | 277.20 Mn |
| Sep 30, 2011 | 277.20 Mn |
| Jun 30, 2011 | 242.20 Mn |
| Dec 31, 2010 | 235.32 Mn |